Acomplia. The weight loss pill that works wonders
Wouldn’t you love the idea of losing up to 10% of your body weight and keeping it at a low level for two years? Welcome to the world of Rimonabant or Acomplia. Chew on this - 33% of people taking this pill lost 10% of body weight and kept their weight down for two years. That’s no mean achievement, as losing 12-15 kilos is a lot of weight off your back. This is nothing short of a miracle as no other diet drug ever accomplished this. Don’t think of obese individuals in isolation, rather think of their complete set of health problems. One thing leads to another, and sure enough, overweight can lead to diabetes, can lead to cardio-vascular problems, it’s a scary chain of scaled up levels of risks.
Naturally, people have been suspicious of Acomplia. How can a pill control weight? Do these things work? The answer is yes and no.Yes, as long as you use the pill along with exercise and diet control. No, if you are looking for a blind remedy while you go on a binge – it’s not gonna work for you then. Now let’s give you more good news. For most patients with diabetes, Accomplia works doubly well. But first, let us understand how Acomplia works.
In easy to understand layman terms, it is an appetite suppressor.
Voila, the brain and body receive a stimulus that reduces the craving to eat more. Now comes the blockbuster part. Acomplia answer’s every physician’s prayers by doing the impossible, your
HDL (good cholesterol) improves, while your triglycerides (bad cholesterol) reduce. As for your craving for cigarettes, Acomplia controls that too. And if you have Type 2 diabetes, then you are lucky to have Acomplia on your side, as it keeps all associated risk factors in check. That;s because some doctors associate management of diabetes with only fall in blood sugar levels, but mature doctors know that weight control has a major role to play in this.And that’s where Acomplia scores over other weight management pills, as the only one to contribute to the overall well being of obese patients esp those with diabetes of type 2.
|
